Connecticut Governor Dannel P. Malloy signed into law Friday a measure requiring better information about the impact of taxpayer money spent to boost Connecticut’s bioscience industry.

Connecticut Innovations, the state’s venture capital firm, will hire a firm to measure the economic impact of the state’s investments in bioscience. The information will be used to determine how employment has grown and also the so-called multiplier effects that increase the impact of initial investments.